Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

DE:YP1B Stock Latest News

Company AnnouncementsImmutep Refocuses Efti Development, Elevates IMP761 as Cash Runway Extends to 20284d ago
Immutep presents HRQoL data from EFTISARC-NEO trialThe FlyImmutep presents HRQoL data from EFTISARC-NEO trial1w agoIMMP
Company AnnouncementsImmutep’s Sarcoma Trial Shows Stable Quality of Life and Post-Surgery Gains1w ago
RatingsImmutep Earns Buy Rating on First-in-Class LAG-3 Agonist IMP761, Strong Phase 1 Data, and Cash Runway Into 20281w agoIMMP
Immutep Restores Nasdaq Bid Price Compliance with ADS Ratio ChangeCompany AnnouncementsImmutep Restores Nasdaq Bid Price Compliance with ADS Ratio Change2w ago
Company AnnouncementsImmutep Moves to Restore ASX Audit Committee Compliance After Director Exit3w ago
Company AnnouncementsImmutep Details Equity Interests of Departing Director Pete Meyers4w ago
Immutep receives A$856,669 cash rebate from Australia R&D tax incentive programThe FlyImmutep receives A$856,669 cash rebate from Australia R&D tax incentive program1M agoIMMP
Company AnnouncementsImmutep boosts R&D funding with multi-jurisdiction tax incentives1M ago
The FlyImmutep Ltd trading halted, news pending1M agoIMMP